Apply for Admission

Graduate School on Facebook 
    Visit us on Facebook!

Duke University Graduate School
2127 Campus Drive
Box 90065
Durham, NC 27708 USA

For comments or suggestions regarding this site, contact the webmaster at

Departments & Programs

Molecular Cancer Biology

For more information contact:

Director of Graduate Studies
University Program in Molecular Cancer Biology
Box 3813 Duke University Medical Center
Durham, NC 27710
(919) 613-8600

General Information

Degree offered: Ph.D.
Faculty working with students: 50
Students: 48
Spring Application: no
Part time study available: no
Test required: GRE General. GRE Subject (Biology or Biochemistry, Cell and Molecular Biology) recommended
Application Deadline 

Program Description

The molecular cancer biologists at Duke University seek to understand the complex regulatory mechanisms that govern mammalian cell growth and differentiation, discern how these mechanisms are perturbed in malignant cells, and how our knowledge of these regulatory mechanisms might lead to improved anti-cancer therapy. This research covers the boundaries of disciplines such as pharmacology, biochemistry, molecular biology, genetics and cell biology, and has increased our knowledge of the basic mechanisms underlying growth regulation. To understand how and why these mechanisms fail, and how their failure results in the initiation of cancer requires an understanding of the molecules involved in chemically and cellularly precise terms, so as to decipher their ultimate impact on the growth and development of the organism. The Program in Molecular Cancer Biology includes faculty from thirteen participating departments. Program scientists are actively engaged in dissecting the regulatory networks that control the processes of growth and development at the cellular and molecular levels, and the defects that lead to oncogenic transformation. The approaches used by the investigators range from classical genetics to cell and molecular biology and protein biochemistry. An ultimate goal is identifying novel candidates for therapeutic intervention of oncogenesis. Graduate training in this program is greatly enhanced by the interaction between investigators.